Summary
Updated Aug 31, 2026
Reshma Rangwala is EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. (KPTI). 5 SEC Form 4 filings on record going back to 2025, most recently on 15 May 2026. Most recent open-market trade: sold $4K of KPTI on 15 May 2026. Lifetime open-market sales: $58K.
Recent Transactions
7Every recent SEC Form 4 transaction Reshma Rangwala has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Reshma Rangwala go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Reshma Rangwala files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard A. Paulson - $145K of KPTI open-market activity in the last 12 months
- Stuart Poulton - $59K of KPTI open-market activity in the last 12 months
- Sohanya Roshan Cheng - $48K of KPTI open-market activity in the last 12 months
- Michael Mano - $37K of KPTI open-market activity in the last 12 months
- Lori Macomber - $10K of KPTI open-market activity in the last 12 months
- Kristin Abate - $10K of KPTI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Reshma Rangwala?
Reshma Rangwala is a corporate insider, tracked as EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. (KPTI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Reshma Rangwala last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 5 filings going back to 2025.
Has Reshma Rangwala been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($58K) across all tracked filings.
Where can I see all of Reshma Rangwala's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Reshma Rangwala and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial